A Study to Explore Tumor Biology in Metastatic Esophageal and Gastric Cancer Patients
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Rochester, Minnesota: 18-001612
Sponsor Protocol Number: 18-001612
About this study
The purpose of this study is to explore various biomarkers in the post-treatment tissue of patients who have responded to cancer therapy and compare it to the biopsy performed prior to cancer treatment.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Age ≥ 18 years old.
- Diagnosis of Stage IV gastric, esophageal, or gastro-esophageal cancer.
- Willing to undergo a biopsy of tumor at participating institution
- Provide written informed consent.
- Willing to provide tissue for research purposes.
- Vulnerable populations: pregnant women, prisoners, mentally handicapped.
- Unable to undergo a biopsy.
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Eligibility last updated 11/11/22. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Harry Yoon, M.D.
Open for enrollment
Cancer Center Clinical Trials Referral Office
Publications are currently not available